phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before.
. "the importance of our new method is that it allows for precise and automated measurement of the disease," bentley added in the study published in the journal radiology.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.imagine a congressional hearing held before media cameras, with reporters all over the us and europe ready with shocking articles about one of the leading causes of death�
.
.